Insider · CIK 0002035295
John Michael Deitzer
cfoofficer
Files at ATKR (Atkore Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | ATKR Atkore Inc. | AGrant or award Common Stock | +36 | $0.00 | $0 | 10,435 | Sep 3, 2025 |
| May 28, 2025 | ATKR Atkore Inc. | AGrant or award Common Stock | +31 | $0.00 | $0 | 10,399 | May 30, 2025 |
| Feb 28, 2025 | ATKR Atkore Inc. | AGrant or award Common Stock | +32 | $0.00 | $0 | 10,368 | Mar 3, 2025 |
| Dec 16, 2024 | ATKR Atkore Inc. | AGrant or award Common Stock | +3 | $0.00 | $0 | 10,336 | Dec 17, 2024 |
| Nov 18, 2024 | ATKR Atkore Inc. | AGrant or award Common Stock | +5,459 | $0.00 | $0 | 10,334 | Nov 20, 2024 |
| Nov 16, 2024 | ATKR Atkore Inc. | FTax withholding Common Stock | -114 | $88.97 | $10k | 4,348 | Nov 19, 2024 |
| Nov 16, 2024 | ATKR Atkore Inc. | AGrant or award Common Stock | +953 | $0.00 | $0 | 5,302 | Nov 19, 2024 |
| Nov 16, 2024 | ATKR Atkore Inc. | FTax withholding Common Stock | -427 | $88.97 | $38k | 4,875 | Nov 19, 2024 |
| Nov 13, 2024 | ATKR Atkore Inc. | FTax withholding Common Stock | -104 | $92.48 | $9,618 | 4,462 | Nov 15, 2024 |
| Aug 30, 2024 | ATKR Atkore Inc. | AGrant or award Common Stock | +5 | $0.00 | $0 | 4,696 | Nov 13, 2024 |
| Nov 11, 2024 | ATKR Atkore Inc. | FTax withholding Common Stock | -130 | $95.73 | $12k | 4,566 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.